drugset / Trial / NCT07389824

Efficacy of Acupuncture-Mesalazine Combination Therapy in Ulcerative Colitis.

NCT07389824

Not yet recruiting 80 enrolled Qin Yu
RandomizedParallel-groupDouble-blindTreatment

Summary

This study aims to evaluate the efficacy and safety of acupuncture combined with mesalazine (an integrated acupuncture-medication regimen) for ulcerative colitis.

Timeline

Start
2026-02-01
Primary completion
2027-09-30
Completion
2027-12-31

Drugs

EvaluationDrugModalityDoseRoute
Background Mesalamine Small molecule 2 g
Background Mesalamine Small molecule 4 g

Indications